Can someone with Hashimoto’s take the new class of Semaglutide, Mounjaro, WeGovy, or Ozempic?

6 Feb 2024 · 2 min
1:55

This YouTube monologue by McCall McPherson addresses whether newer GLP‑1/GIP weight-loss medications (semaglutide/Ozempic/Wegovy, tirzepatide/Mounjaro) are contraindicated for people with Hashimoto’s hypothyroidism. McPherson argues they are not contraindicated and reports clinical observations that these drugs can reduce TPO and thyroglobulin antibody levels, lower systemic inflammation, and rehabilitate metabolic dysfunction (insulin resistance and impaired weight-loss ability), while warning against widespread misinformation.

Chapters

More from McCall

1:27
youtube.com

GLPs: The Future of Disordered Eating Treatment? #shorts

today
0:34
youtube.com

GLP-1s: Unlock Longer Life & Fight Heart Disease! #shorts

1d ago
0:40
youtube.com

Thyroid Hormones: T4 Risks vs. T3 Benefits Explained! #shorts

1d ago
42:12
youtube.com

Insulin Resistance Changes Everything

1d ago
1:42
youtube.com

Thyroid Hormones: T4 Risks vs. T3 Benefits! #shorts

2d ago
1:42
youtube.com

Thyroid Lab Ranges: Are They Based On Sick People? #shorts

2d ago
1:57
youtube.com

Is It ADHD, Your Thyroid, or Both? #shorts

6d ago
1:12
youtube.com

ADHD & Endometriosis: The Surprising Health Connection #shorts

6d ago
1:53
youtube.com

Understanding ADHD in Women

1w ago
2:09
youtube.com

Unlock Thyroid Health: Myo-Inositol & Selenium Power #shorts

1w ago
45:57
youtube.com

Is It ADHD or Your Hormones? The Thyroid & Perimenopause Connection with Dr. Jolene Brighten

1w ago
See all content